Beta
Felbamate
medication Under reviewAn anticonvulsant medication used for the treatment of refractory epilepsy.
Research summary
AI-Generated Content:
This summary was created by AI and may contain errors. Always verify with peer-reviewed sources.
Scientific evidence supports felbamate's efficacy as adjunctive therapy in drug-resistant epilepsy, with responder rates around 65% and seizure freedom in about 17% of cases across reviewed studies. Retention rates remain high at approximately 83%, indicating good long-term tolerability under strict monitoring, though no controlled studies exist specifically in healthy human subjects.
No side effects tracked yet
No side effects have been reported by studies or users for this habit yet.
Research
No studies found yet. Request research to discover relevant studies.
Community updates
No updates yet for this supplement.
Be the first to share your experience!
At a glance
Users tracking
0
Linked studies
0
Researched benefits
0
Side effects noted
0